TD Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $169M | Sell |
|
|||||
|
2025
Q1 | $223M | Sell |
|
|||||
|
2024
Q4 | $256M | Buy |
|
|||||
|
2024
Q3 | $344M | Sell |
|
|||||
|
2024
Q2 | $369M | Buy |
|
|||||
|
2024
Q1 | $259M | Buy |
|
|||||
|
2023
Q4 | $90M | Sell |
|
|||||
|
2023
Q3 | $148M | Buy |
|
|||||
|
2023
Q2 | $78.8M | Sell |
|
|||||
|
2023
Q1 | $92.1M | Buy |
|
|||||
|
2022
Q4 | $74.1M | Buy |
|
|||||
|
2022
Q3 | $63.9M | Buy |
|
|||||
|
2022
Q2 | $51.6M | Buy |
|
|||||
|
2022
Q1 | $56.9M | Sell |
|
|||||
|
2021
Q4 | $51.6M | Buy |
|
|||||
|
2021
Q3 | $48.4M | Sell |
|
|||||
|
2021
Q2 | $46.4M | Buy |
|
|||||
|
2021
Q1 | $37.2M | Buy |
|
|||||
|
2020
Q4 | $36.6M | Buy |
|
|||||
|
2020
Q3 | $41.8M | Buy |
|
|||||
|
2020
Q2 | $43.3M | Buy |
|
|||||
|
2020
Q1 | $29.9M | Buy |
|
|||||
|
2019
Q4 | $19.7M | Sell |
|
|||||
|
2019
Q3 | $16.2M | Buy |
|
|||||
|
2019
Q2 | $17.8M | Sell |
|
|||||
|
2019
Q1 | $27.8M | Buy |
|
|||||
|
2018
Q4 | $17.9M | Buy |
|
|||||
|
2018
Q3 | $18.5M | Sell |
|
|||||
|
2018
Q2 | $17.2M | Buy |
|
|||||
|
2018
Q1 | $16.6M | Sell |
|
|||||
|
2017
Q4 | $18.2M | Sell |
|
|||||
|
2017
Q3 | $21.8M | Sell |
|
|||||
|
2017
Q2 | $25.6M | Sell |
|
|||||
|
2017
Q1 | $24.9M | Sell |
|
|||||
|
2016
Q4 | $23.7M | Sell |
|
|||||
|
2016
Q3 | $27.3M | Sell |
|
|||||
|
2016
Q2 | $30.1M | Sell |
|
|||||
|
2016
Q1 | $35.1M | Sell |
|
|||||
|
2015
Q4 | $61.9M | Buy |
|
|||||
|
2015
Q3 | $51.5M | Buy |
|
|||||
|
2015
Q2 | $50.4M | Buy |
|
|||||
|
2015
Q1 | $39.1M | Buy |
|
|||||
|
2014
Q4 | $35.4M | Buy |
|
|||||
|
2014
Q3 | $29.1M | Buy |
|
|||||
|
2014
Q2 | $21.5M | Sell |
|
|||||
|
2014
Q1 | $30.8M | Sell |
|
|||||
|
2013
Q4 | $32.7M | Sell |
|
|||||
|
2013
Q3 | $37.9M | Sell |
|
|||||
|
2013
Q2 | $28.2M | Buy |
|